Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: Five-year results of a randomized controlled trial

Journal of Vascular Surgery

Volumn 37, Issue 1, 2003, Pages 149-155

  Klinkert, Pieter ^a   Schepers, Abbey ^a   Burger, Desirée H C ^a   Van Bockel, J Hajo ^b   Breslau, Paul J ^a  

^a Red Cross Hospital Den Haag   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; CEFAMANDOLE; HEPARIN; POLITEF;

ABOVE KNEE AMPUTATION; ADULT; AGED; ARTICLE; BELOW KNEE AMPUTATION; BLOOD VESSEL GRAFT; BLOOD VESSEL SHUNT; BYPASS SURGERY; CLAUDICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GRAFT PATENCY; HUMAN; INTERMETHOD COMPARISON; KNEE; LEG PAIN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SAPHENOUS VEIN GRAFT; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037285659     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.86     Document Type: Article

References (20)

1. Bergan JJ, Veith FJ, Bernhard VM, Yao JS, Flinn WR, Gupta SK, et al. Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. Surgery 1982;92:921-30.
2. Londrey GL, Ramsey DE, Hodgson KJ, Barkmeier LD, Sumner DS. Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg 1991;13:631-6.
3. Sayers RD, Raptis S, Berce M, Miller JH. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg 1998;85:934-8.
4. Van de Pavoordt HD, Eikelboom BC, De Geest R, Vermeulen FE. Results of prosthetic grafts in femoro-crural bypass operations as compared to autogenous saphenous vein grafts. Neth J Surg 1986;38:177-9.
5. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
6. O'Riordain DS, Buckley DJ, O'Donnell JA. Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 1992;164:129-31.
7. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD, et al. Long-term results of infrainguinal revascularization with polyretrafluoroethylene: a ten-year experience. J Vasc Surg 1992;16:209-17.
8. Abbott WM, Green RM, Matsumoto T, Wheeler JR, Miller N, Veith FJ, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group [see comments]. J Vasc Surg 1997;25:19-28.
9. Burger DH, Kappetein AP, Van Bockel JH, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting [see comments]. J Vasc Surg 2000;32:278-83.
10. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 1999;126:594-601.
11. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoralpopliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-77.
12. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
13. Mills JL. P values may lack power: the choice of conduit for above-knee femoropopliteal bypass graft. J Vasc Surg 2000;32:402-5.
14. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976;34:585-612.
15. Michaels JA. Choice of material for above-knee femoropopliteal bypass graft. Br J Surg 1989;76:7-14.
16. Evans LE, Webster MW, Brooks DH, Bahnson HT. Expanded polyretrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up. Surgery 1981;89:16-22.
17. Prendiville EJ, Yeager A, O'Donnell TF Jr., Coleman JC, Jaworek A, Callow AD, et al. Long-term results with the above-knee popliteal expanded polyretrafluoroethylene graft. J Vasc Surg 1990;11:517-24.
18. Rutherford RB, Jones DN, Bergentz SE, Bergqvist D, Comerota AJ, Dardik H, et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988;8:236-46.
19. Poletti LF, Matsuura JH, Dattilo JB, Posner MP, Lee HM, Scouvart M, et al. Should vein be saved for future operations? A 15-year review of infrainguinal bypasses and the subsequent need for autogenous vein. Ann Vasc Surg 1998;12:143-7.
20. Sterpetti AV, Schultz RD, Feldhaus RJ, Peetz DJ Jr. Seven-year experience with polyretrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein? J Vasc Surg 1985;2:907-12.